Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition terminology update, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T20:14:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-17T21:48:35.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:00:59.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is currently inaccessible. This affects page accessibility but not the underlying study information.
    Difference
    18%
    Check dated 2026-09-19T20:52:54.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page footer revision label updated from Revision: v3.6.5 to Revision: v3.6.6, signaling a new software build. It does not change the study details or user workflow on the page.
    Difference
    0.1%
    Check dated 2026-08-29T21:58:07.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor maintenance update to the site’s revision labeling.
    Difference
    0.0%
    Check dated 2026-08-08T17:34:32.000Z thumbnail image

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.